JAMES MAGNER, M.D.
Osteopathic Medicine at Field Dr, New Haven, CT
License number
Connecticut 36265
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
1022 Field Dr, New Haven, CT 06525
Phone
(475) 227-6740
Personal information
See more information about JAMES MAGNER at radaris.comName
Address
Phone
122 Foote Rd, South Glastonbury, CT 06073
122 Foote, Glastonbury, CT 06033
122 Foote Rd, South Glastonbury, CT 06073
122 Foote Rd, South Glastonbury, CT 06073
Organization information
See more information about JAMES MAGNER at bizstanding.comJames A Magner MD
1022 Fld Dr, New Haven, CT 06525
Industry:
Medical Doctor's Office, Internist
Doing business as:
James Magner MD
Phone:
(203) 812-2588 (Phone)
Principal:
James A. Magner (Principal)
Professional information
See more information about JAMES MAGNER at trustoria.com
James Arthur Magner, West Haven CT
James Arthur Magner, West Haven CT
Specialties:
Internal Medicine, Endocrinology and Metabolism, Endocrinology, Diabetes & Metabolism
Work:
Bayer Corp
400 Morgan Ln, West Haven, CT 06516
400 Morgan Ln, West Haven, CT 06516
Education:
University of Chicago (1977)
Dr. James A Magner, Woodbridge CT - MD (Doctor of Medicine)
Dr. James A Magner, Woodbridge CT - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism
Address:
1022 Field Dr, Woodbridge 06525
Certifications:
Diabetes, Metabolism & Endocrinology, 1983, Internal Medicine, 1980
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1977
U Tex Hlth Sci Ctr
National Institutes Of Health Clinical Center
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1977
U Tex Hlth Sci Ctr
National Institutes Of Health Clinical Center
Formulations For Therapeutic Administration Of Thyroid Stimulating Hormone (Tsh)
Formulations For Therapeutic Administration Of Thyroid Stimulating Hormone (Tsh)
US Patent:
2010004, Feb 25, 2010
Filed:
Sep 18, 2007
Appl. No.:
12/441836
Inventors:
Eliana Clark - Boylston MA, US
James Magner - Woodbridge CT, US
Jeffrey Skell - Westborough MA, US
James Magner - Woodbridge CT, US
Jeffrey Skell - Westborough MA, US
International Classification:
A61K 38/22, A61P 5/14
US Classification:
514 5
Abstract:
This disclosure generally relates to novel formulations containing the active ingredient thyroid stimulating hormone (TSH) having modified pharmacokinetic profiles as compared to prior art formulations.